Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
BAKER BROS. ADVISORS LP (CIK 1263508) reported $17.42B across 77 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: INCY ($2.89B, 16.62%), ONC ($2.61B, 15.00%), INSM ($1.21B, 6.97%), MDGL ($1.12B, 6.44%), ACAD ($954.9M, 5.48%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | $2.89B | 16.62% | 30.7M | Added |
| 2 | ONC | BeOne Medicines Ltd. | $2.61B | 15.00% | 8.8M | Hold |
| 3 | INSM | Insmed Incorporated | $1.21B | 6.97% | 7.4M | Added |
| 4 | MDGL | Madrigal Pharmaceuticals, Inc. | $1.12B | 6.44% | 2.1M | Hold |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | $954.9M | 5.48% | 42.9M | Hold |
| 6 | RVMD | Revolution Medicines, Inc. | $929.3M | 5.34% | 9.6M | Added |
| 7 | CELC | Celcuity Inc. | $903.5M | 5.19% | 7.9M | Hold |
| 8 | KOD | Kodiak Sciences Inc. | $759.3M | 4.36% | 19.9M | Hold |
| 9 | KYMR | Kymera Therapeutics, Inc. | $721.1M | 4.14% | 8.7M | Hold |
| 10 | SMMT | Summit Therapeutics Inc. | $690.0M | 3.96% | 36.4M | Hold |
| 11 | PRAX | Praxis Precision Medicines, Inc. | $564.9M | 3.24% | 1.8M | Added |
| 12 | RYTM | Rhythm Pharmaceuticals, Inc. | $487.4M | 2.80% | 5.6M | Hold |
| 13 | ALKS | Alkermes plc | $354.0M | 2.03% | 10.0M | Hold |
| 14 | GRAL | GRAIL, Inc. | $208.2M | 1.20% | 4.0M | Added |
| 15 | EWTX | Edgewise Therapeutics, Inc. | $207.1M | 1.19% | 6.6M | Hold |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | $153.8M | 0.88% | 2.0M | Added |
| 17 | KNSA | Kiniksa Pharmaceuticals International, plc | $136.1M | 0.78% | 2.8M | Hold |
| 18 | IMVT | Immunovant, Inc. | $135.6M | 0.78% | 5.5M | Hold |
| 19 | ROIV | Roivant Sciences Ltd. | $134.8M | 0.77% | 4.9M | Trimmed |
| 20 | IDYA | IDEAYA Biosciences, Inc. | $131.5M | 0.76% | 3.9M | Added |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | $124.9M | 0.72% | 2.0M | Trimmed |
| 22 | IMTX | Immatics N.V. | $107.4M | 0.62% | 10.9M | Trimmed |
| 23 | STOK | Stoke Therapeutics, Inc. | $108.6M | 0.62% | 3.3M | Hold |
| 24 | ABCL | AbCellera Biologics Inc. | $105.7M | 0.61% | 30.3M | Added |
| 25 | ABVX | Abivax S.A. | $97.5M | 0.56% | 875,796 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31